EBS:NYSE
Emergent Biosolutions Inc
6,96 $
arrow_upward
+0,72%(+0,050) 1 d.
14. okt., 14:30:50 GMT-4 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: EBS…
Atvērt
6,87 $
Augsta
7,07 $
Zema
6,81 $
Tirgus kapitalizācija
356,86 milj.
Vid. apjoms
1,14 milj.
Apjoms
371,92 tūkst.
Augstākā 52 ned.
14,06 $
Zemākā 52 ned.
4,36 $
Peļņa uz vienu akciju
-3,51 $
Beta
2,28
Apgrozībā esošās akcijas
51,27 milj.
Darbinieku skaits
900
Atvērt
6,87 $
Augsta
7,07 $
Zema
6,81 $
Tirgus kapitalizācija
356,86 milj.
Vid. apjoms
1,14 milj.
Apjoms
371,92 tūkst.
Augstākā 52 ned.
14,06 $
Zemākā 52 ned.
4,36 $
Peļņa uz vienu akciju
-3,51 $
Beta
2,28
Apgrozībā esošās akcijas
51,27 milj.
Darbinieku skaits
900
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
The Daily News | Texas' Oldest Newspaper
·
pirms 33 minūtēm
Federal Reserve Chair Jerome Powell interest rate announcement at the New York Stock Exchange (NYSE) in New York City
Seeking Alpha
·
pirms 14 minūtēm
Nasdaq tumbles 2%, and these 10 stocks have fueled the selloff
24/7 Wall St.
·
pirms 2 stundām
Michael Burry Says Stocks Could Peak Within 9 Months — and He’s Betting Against the Nasdaq and Chip Stocks
Profils
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Par “Emergent Biosolutions Inc”
ĢenerāldirektorsRobert G. Kramer Sr. | Joseph C. Papa
Darbinieki900
Dibināšanas datums1998. gada 5. sept.
Galvenais birojsRockville, Merilenda, Amerikas Savienotās Valstis
Sektors-
Tīmekļa vietneemergentbiosolutions.com